SCHEMBL29934754

SCHEMBL29934754

CC(C)c1ccc(-c2cc(N)c(C#N)c3c2OCC3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.42
HPGD P15428 7/20 0.42
NPSR1 Q6W5P4 5/20 0.34
MAPK1 P28482 2/20 0.34
ALDH1A1 P00352 7/20 0.32
RXFP1 Q9HBX9 3/20 0.32
PPARG P37231 1/20 0.32
STAT3 P40763 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
SLC5A1 P13866 1/20 0.32
SLC5A2 P31639 1/20 0.32
HSD17B10 Q99714 3/20 0.32
LMNA P02545 2/20 0.32
GAA P10253 2/20 0.32
ERBB2 P04626 1/20 0.32
XDH P47989 2/20 0.31
SLC22A12 Q96S37 1/20 0.31
ADORA1 P30542 1/20 0.31
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23363867 1.00 KDM4E (0.42) KDM4EHPGDNPSR1MAPK1ALDH1A1
SCHEMBL25218603 0.88 HPGD (0.38) KDM4EHPGDNPSR1MAPK1ALDH1A1
SCHEMBL30460367 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL30460355 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL30460617 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL25064015 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL25064016 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL25064026 0.88 KDM4E (0.32) KDM4EHPGD
SCHEMBL25064008 0.84 KDM4E (0.33) KDM4EHPGD
SCHEMBL30364100 0.84 KDM4E (0.33) KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340883-A1 COMBINATION THERAPY GENENTECH, INC. (US) 2024-03-27 EP disclosed
CN-117337193-A combination therapy 基因泰克公司 2024-01-02 CN disclosed
CN-116234797-A Heterocyclic inhibitors of TEAD for the treatment of cancer 基因泰克公司 2023-06-06 CN disclosed
EP-4185386-A1 HETEROCYCLIC INHIBITORS OF TEAD FOR TREATING CANCER Genentech, Inc. (US) 2023-05-31 EP disclosed
WO-2022246459-A9 COMBINATION THERAPY GENENTECH, INC. (US) 2023-01-05 WO disclosed
WO-2022246459-A1 COMBINATION THERAPY GENENTECH, INC. (US) 2022-11-24 WO disclosed
EP-4058435-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2022-09-21 EP disclosed